S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Urgent alert: open this for a huge profit potential (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Urgent alert: open this for a huge profit potential (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Urgent alert: open this for a huge profit potential (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Urgent alert: open this for a huge profit potential (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Free Trial

Compare Stocks

→ The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare
No chart data

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
$2.55
+2.0%		$0.00
$0.15
▼
$1.37
$85.35MN/A842,200 shs31,015 shs
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/A0.00∞N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/A

Insider Ownership

CompanyInsider Ownership
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ampliphi Biosciences Corp stock logo
APHB
Ampliphi Biosciences
3033.47 millionN/ANot Optionable

APHB Headlines

SourceHeadline
Pacific Biosciences Stock (NASDAQ:PACB), Analyst Ratings, Price Targets, PredictionsPacific Biosciences Stock (NASDAQ:PACB), Analyst Ratings, Price Targets, Predictions
benzinga.com - October 24 at 10:52 PM
Aphb Colony Pin CodeAphb Colony Pin Code
indiatvnews.com - July 26 at 8:42 PM
Aphb Colony Moulali Pin CodeAphb Colony Moulali Pin Code
indiatvnews.com - February 26 at 7:37 AM
Akston Biosciences Strengthens Board with Addition of John T. PrestonAkston Biosciences Strengthens Board with Addition of John T. Preston
finance.yahoo.com - January 25 at 8:36 PM
Selecta Biosciences Stock (NASDAQ:SELB), Quotes and News SummarySelecta Biosciences Stock (NASDAQ:SELB), Quotes and News Summary
benzinga.com - January 5 at 5:43 PM
APHB: Case Study on AB-PA01 Presented at ISHLT Annual MeetingAPHB: Case Study on AB-PA01 Presented at ISHLT Annual Meeting
finance.yahoo.com - October 27 at 12:59 AM

Media Sentiment Over Time

Company Descriptions

Ampliphi Biosciences logo

Ampliphi Biosciences

NYSEAMERICAN:APHB
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.